Neurofibroma classification

Jump to navigation Jump to search

Neurofibroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neurofibroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neurofibroma classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurofibroma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurofibroma classification

CDC on Neurofibroma classification

Neurofibroma classification in the news

Blogs on Neurofibroma classification

Directions to Hospitals Treating Neurofibroma

Risk calculators and risk factors for Neurofibroma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]

Overview

Neurofibroma may be classified into 5 subtypes: cutaneous/dermal/localized, localized intraneural, subcutaneous, diffuse, intramuscular, plexiform and pigmented neurofibroma. Plexiform neurofibromas may be further sub-classified into diffuse and nodular plexiform.

Classification

Neurofibroma may be classified into following subtypes:[1][2][3][4]

Types of neurofibromas Characteristics/Description
Cutaneous/Dermal/Localized/Sporadic neurofibroma (90%)
Localized Intraneural neurofibroma
Subcutaneous neurofibroma
Diffuse neurofibroma

(superficial)

Intramuscular neurofibroma
Plexiform neurofibroma

(deep)

  • Deep
  • Associated with NF1
  • Diffuse involvement along a large nerve and its branches
  • Mostly internal/ intraneural
  • Can also involve small nerves and superficial skin
  • Have more connective tissue/extracellular matrix than cutaneous neurofibromas, that separates the nerve fibers
  • Gross enlargement of the nerve with nodular tumor development results in the gross pathologic appearance referred to as “bag of worms”
  • Generally believed to be present at birth (congenital)
  • Disfiguring
  • Affects function due to sheer size as well as neurovascular compromise
  • Upto 5% risk of malignant transformation
  • Plexiform neurofibroma exhibits following features on T2-weighted MRI:
    • Target sign (low signal intensity centrally with a ring of high signal intensity peripherally)
    • Fascicular sign
    • May appear as a larger and more infiltrating mass with lobulated borders with inhomogeneous enhancement
Pigmented neurofibroma
  • Neurofibroma with melanin-bearing pigmented cells, usually only appreciated microscopically
  • Not considered a true subtype
  • No increased risk of malignant transformation

Plexiform neurofibromas can be further subclassified into following:[5]

Types of neurofibromas Characteristics/Description
Diffuse Plexiform neurofibroma
Nodular Plexiform neurofibroma

References


Template:WikiDoc Sources